China Life Science 2010: A Giant Leap Forward

On the calendar, 2010 wasn’t an actual leap year. Nevertheless, it was a leap year for China life science. VC investments, IPOs, M&A activity, partnerships, patents and government funds – all of these important metrics established new records during 2010 in China’s life science sector, as tabulated by proprietary ChinaBio® research. In other words, the promise of China, for so long a source of much discussion in global life science circles, has become fact. Do you want examples? VC investment in China life science exceeded $1 billion for the first time; the year saw the first venture capital investment in China to top $100 million; a record 33 life science IPOs raised nearly $6 billion U.S., M&A activity rose 8-fold to $3.4 billion U.S., and much more. See the full report, China Life Science 2010: A Giant Leap Forward . Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});